佛罗里达州迈阿密市梅克尔细胞癌患者的数据:回顾性分析

Kayla D. Mashoudy, Anil Dalling, Caitlin Dowell-Esquivel, Peyton V. Warp, Robert S. Kirsner
{"title":"佛罗里达州迈阿密市梅克尔细胞癌患者的数据:回顾性分析","authors":"Kayla D. Mashoudy,&nbsp;Anil Dalling,&nbsp;Caitlin Dowell-Esquivel,&nbsp;Peyton V. Warp,&nbsp;Robert S. Kirsner","doi":"10.1002/jvc2.475","DOIUrl":null,"url":null,"abstract":"<p>Inadequate literature has analyzed Merkel cell carcinoma (MCC) in ethnically diverse Hispanic and Black populations. Considering the rising proportion of MCC in such minority groups<span><sup>1</sup></span> and the racial and ethnic heterogeneity of Miami-Dade County, we reviewed MCC data for patients in Miami, Florida.</p><p>In this study, approved by the University of Miami Institutional Review Board, electronic medical records of 191 patients seen at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine from January 2010 to February 2023 were examined retrospectively by two reviewers, P. V. W. and C. D.-E. The <i>χ</i><sup>2</sup> tests of independence and goodness-of-fit were used to verify any statistical significance between the observed and expected MCC rates in this patient group (<i>p</i> &lt; 0.05).</p><p>Patient demographics and variables are examined in Tables 1 and 2, respectively. Of the 191 patients diagnosed with MCC, most patients (178 of the 191 or 93%) were White; of which 56 or 31% where White Hispanic. Seventy-one percent (136) were men and 81% (155) were over the age of 60 years old. The median time from symptom onset to diagnosis was 98 days. Significantly more tumours were located on the face/head/neck than on the trunk or limbs (<i>p</i> = 0.00). At diagnosis, most tumours were stage I or stage III (<i>p</i> = 0.00) and small (size ≤ 2 cm, <i>p</i> = 0.00). MCC was more common in men than in women, with differences in stage at diagnosis (<i>p</i> = 0.03) and regional lymph node status (<i>p</i> = 0.01) between the two sexes also being significant. Women were more likely to present at a lower stage and negative regional lymph node status, signifying nonmetastatic disease. Out of the 126 patients with known primary or secondary MCC, a significant majority (96 of 126 or 76.2%) had primary MCC. Most patients (132 of 187 or 70.6%) were also referred from another facility for treatment (<i>p</i> = 0.00) and had no other concurrent malignancy (110 of 165 or 66.7%, <i>p</i> = 0.00).</p><p>These results illustrate characteristics of MCC in a distinct, regionally Hispanic-predominant population. About one-third of the study population identified as Hispanic, and the majority of tumours were located on anatomical sites regularly exposed to sunlight. Although identification with an ethnic or racial group can be impacted by factors like skin colour, generational status and geographical nativity,<span><sup>2</sup></span> our results suggest that actinic damage likely influences the development of MCC even in Hispanic populations. Moreover, most women in our cohort had nonmetastatic disease at presentation while most men had metastatic disease at presentation, suggesting possible delay in diagnosis, preferential referral to the University or more aggressive biology in men. It is known that MCC is a highly aggressive tumour, with metastasis being associated with lower survival rates and poorer outcomes.<span><sup>3</sup></span> These findings align with recently published data showing women have improved survival.<span><sup>4</sup></span> Interestingly, however, the range of time from symptom onset to diagnosis (20–638 days) was less than that of other tertiary care centres with similar published data.<span><sup>5</sup></span></p><p>Although polyomavirus status in the study population was not found to be statistically significant, only about 25% (47 of 191) of our cohort underwent Merkel cell polyomavirus (MCPyV) testing. A total of 26 of these 47 patients (55.3%) were found to be virus-negative as compared to prior studies confirming MCPyV+ status in approximately 80% of cases.<span><sup>6, 7</sup></span> Because MCPyV+ tumours have a better prognosis than MCPyV− tumours, identifying viral status is essential for prognostic predictability,<span><sup>7</sup></span> especially in populations more likely to have sun-protected dark skin like Hispanic and Black patients. UV-driven versus virus-positive MCC prognostic data is still lacking for these populations even in large cohort studies,<span><sup>4, 8</sup></span> and future studies are needed to see how viral status affects their MCC-specific survival.</p><p>Study conception and design, data interpretation, and draft manuscript preparation were performed by Kayla D. Mashoudy. Data analysis and interpretation and material preparation were performed by Anil Dalling. Data collection was done by Caitlin Dowell-Esquivel and Peyton V. Warp. Robert S. Kirsner commented on previous versions of the manuscript and reviewed the final manuscript. All authors reviewed the results and approved the final version of the manuscript.</p><p>The authors declare no conflict of interest.</p><p>This study was reviewed and approved by the University of Miami Institutional Review Board; approval #20230362. This material is the authors' own original work, which has not been previously published elsewhere.</p>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"3 5","pages":"1668-1672"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.475","citationCount":"0","resultStr":"{\"title\":\"Merkel cell carcinoma data for patients in Miami, Florida: A retrospective analysis\",\"authors\":\"Kayla D. Mashoudy,&nbsp;Anil Dalling,&nbsp;Caitlin Dowell-Esquivel,&nbsp;Peyton V. Warp,&nbsp;Robert S. Kirsner\",\"doi\":\"10.1002/jvc2.475\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Inadequate literature has analyzed Merkel cell carcinoma (MCC) in ethnically diverse Hispanic and Black populations. Considering the rising proportion of MCC in such minority groups<span><sup>1</sup></span> and the racial and ethnic heterogeneity of Miami-Dade County, we reviewed MCC data for patients in Miami, Florida.</p><p>In this study, approved by the University of Miami Institutional Review Board, electronic medical records of 191 patients seen at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine from January 2010 to February 2023 were examined retrospectively by two reviewers, P. V. W. and C. D.-E. The <i>χ</i><sup>2</sup> tests of independence and goodness-of-fit were used to verify any statistical significance between the observed and expected MCC rates in this patient group (<i>p</i> &lt; 0.05).</p><p>Patient demographics and variables are examined in Tables 1 and 2, respectively. Of the 191 patients diagnosed with MCC, most patients (178 of the 191 or 93%) were White; of which 56 or 31% where White Hispanic. Seventy-one percent (136) were men and 81% (155) were over the age of 60 years old. The median time from symptom onset to diagnosis was 98 days. Significantly more tumours were located on the face/head/neck than on the trunk or limbs (<i>p</i> = 0.00). At diagnosis, most tumours were stage I or stage III (<i>p</i> = 0.00) and small (size ≤ 2 cm, <i>p</i> = 0.00). MCC was more common in men than in women, with differences in stage at diagnosis (<i>p</i> = 0.03) and regional lymph node status (<i>p</i> = 0.01) between the two sexes also being significant. Women were more likely to present at a lower stage and negative regional lymph node status, signifying nonmetastatic disease. Out of the 126 patients with known primary or secondary MCC, a significant majority (96 of 126 or 76.2%) had primary MCC. Most patients (132 of 187 or 70.6%) were also referred from another facility for treatment (<i>p</i> = 0.00) and had no other concurrent malignancy (110 of 165 or 66.7%, <i>p</i> = 0.00).</p><p>These results illustrate characteristics of MCC in a distinct, regionally Hispanic-predominant population. About one-third of the study population identified as Hispanic, and the majority of tumours were located on anatomical sites regularly exposed to sunlight. Although identification with an ethnic or racial group can be impacted by factors like skin colour, generational status and geographical nativity,<span><sup>2</sup></span> our results suggest that actinic damage likely influences the development of MCC even in Hispanic populations. Moreover, most women in our cohort had nonmetastatic disease at presentation while most men had metastatic disease at presentation, suggesting possible delay in diagnosis, preferential referral to the University or more aggressive biology in men. It is known that MCC is a highly aggressive tumour, with metastasis being associated with lower survival rates and poorer outcomes.<span><sup>3</sup></span> These findings align with recently published data showing women have improved survival.<span><sup>4</sup></span> Interestingly, however, the range of time from symptom onset to diagnosis (20–638 days) was less than that of other tertiary care centres with similar published data.<span><sup>5</sup></span></p><p>Although polyomavirus status in the study population was not found to be statistically significant, only about 25% (47 of 191) of our cohort underwent Merkel cell polyomavirus (MCPyV) testing. A total of 26 of these 47 patients (55.3%) were found to be virus-negative as compared to prior studies confirming MCPyV+ status in approximately 80% of cases.<span><sup>6, 7</sup></span> Because MCPyV+ tumours have a better prognosis than MCPyV− tumours, identifying viral status is essential for prognostic predictability,<span><sup>7</sup></span> especially in populations more likely to have sun-protected dark skin like Hispanic and Black patients. UV-driven versus virus-positive MCC prognostic data is still lacking for these populations even in large cohort studies,<span><sup>4, 8</sup></span> and future studies are needed to see how viral status affects their MCC-specific survival.</p><p>Study conception and design, data interpretation, and draft manuscript preparation were performed by Kayla D. Mashoudy. Data analysis and interpretation and material preparation were performed by Anil Dalling. Data collection was done by Caitlin Dowell-Esquivel and Peyton V. Warp. Robert S. Kirsner commented on previous versions of the manuscript and reviewed the final manuscript. All authors reviewed the results and approved the final version of the manuscript.</p><p>The authors declare no conflict of interest.</p><p>This study was reviewed and approved by the University of Miami Institutional Review Board; approval #20230362. This material is the authors' own original work, which has not been previously published elsewhere.</p>\",\"PeriodicalId\":94325,\"journal\":{\"name\":\"JEADV clinical practice\",\"volume\":\"3 5\",\"pages\":\"1668-1672\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.475\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JEADV clinical practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jvc2.475\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JEADV clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jvc2.475","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

缺乏文献分析默克尔细胞癌(MCC)在不同种族的西班牙裔和黑人人群。考虑到MCC在这些少数群体中比例的上升,以及迈阿密-戴德县的种族和民族异质性,我们回顾了佛罗里达州迈阿密患者的MCC数据。在这项由迈阿密大学机构审查委员会批准的研究中,从2010年1月到2023年2月,迈阿密大学米勒医学院西尔维斯特综合癌症中心的191名患者的电子病历由两位审稿人P. V. W.和C. d . e .回顾性检查。采用χ2独立性检验和拟合优度检验验证该患者组中MCC的观察率与预期率之间是否有统计学意义(p < 0.05)。患者人口统计数据和变量分别在表1和表2中进行了检查。在191例诊断为MCC的患者中,大多数患者(191例中的178例或93%)是白人;其中56个或31%是西班牙白人。71%(136人)为男性,81%(155人)年龄超过60岁。从症状出现到诊断的中位时间为98天。肿瘤位于面部、头颈部明显多于躯干和四肢(p = 0.00)。诊断时,大多数肿瘤为I期或III期(p = 0.00),肿瘤体积较小(≤2 cm, p = 0.00)。男性比女性更常见MCC,两性在诊断分期(p = 0.03)和区域淋巴结状态(p = 0.01)上也有显著差异。女性更有可能出现在较低的阶段和阴性的区域淋巴结状态,这意味着非转移性疾病。在126例已知的原发性或继发性MCC患者中,绝大多数(126例中的96例或76.2%)为原发性MCC。大多数患者(187例中的132例或70.6%)也从其他机构转介治疗(p = 0.00),并且没有其他并发恶性肿瘤(165例中的110例或66.7%,p = 0.00)。这些结果说明了MCC的特点,在一个独特的,区域西班牙裔为主的人口。大约三分之一的研究人群被确定为西班牙裔,大多数肿瘤位于经常暴露在阳光下的解剖部位。虽然对种族或种族群体的认同可能受到肤色、代际地位和出生地等因素的影响,但我们的研究结果表明,即使在西班牙裔人群中,光化损伤也可能影响MCC的发展。此外,在我们的队列中,大多数女性在发病时患有非转移性疾病,而大多数男性在发病时患有转移性疾病,这可能表明诊断延迟,优先转诊到大学或男性更具侵袭性的生物学。众所周知,MCC是一种高度侵袭性的肿瘤,其转移与较低的生存率和较差的预后有关这些发现与最近公布的数据一致,数据显示女性的存活率有所提高然而,有趣的是,从症状发作到诊断的时间范围(20-638天)比其他具有类似公开数据的三级保健中心短。虽然研究人群中的多瘤病毒状态没有发现统计学意义,但我们的队列中只有25%(191人中有47人)接受了默克尔细胞多瘤病毒(MCPyV)检测。在这47例患者中,共有26例(55.3%)被发现为病毒阴性,而之前的研究证实,大约80%的病例呈MCPyV+状态。6,7由于MCPyV+肿瘤的预后比MCPyV -肿瘤好,因此确定病毒状态对于预后的可预测性至关重要,特别是在西班牙裔和黑人患者等更可能拥有晒黑皮肤的人群中。即使在大型队列研究中,这些人群的紫外线驱动与病毒阳性MCC预后数据仍然缺乏4,8,未来的研究需要了解病毒状态如何影响他们的MCC特异性生存。研究构思和设计、数据解释和草稿准备由Kayla D. Mashoudy完成。由Anil Dalling进行数据分析、解释和资料准备。数据收集工作由Caitlin dowwell - esquivel和Peyton V. Warp完成。Robert S. Kirsner评论了之前的手稿版本,并审阅了最终的手稿。所有作者审查了结果并批准了手稿的最终版本。作者声明无利益冲突。本研究由迈阿密大学机构审查委员会审查并批准;批准# 20230362。这些材料是作者自己的原创作品,以前没有在其他地方发表过。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Merkel cell carcinoma data for patients in Miami, Florida: A retrospective analysis

Inadequate literature has analyzed Merkel cell carcinoma (MCC) in ethnically diverse Hispanic and Black populations. Considering the rising proportion of MCC in such minority groups1 and the racial and ethnic heterogeneity of Miami-Dade County, we reviewed MCC data for patients in Miami, Florida.

In this study, approved by the University of Miami Institutional Review Board, electronic medical records of 191 patients seen at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine from January 2010 to February 2023 were examined retrospectively by two reviewers, P. V. W. and C. D.-E. The χ2 tests of independence and goodness-of-fit were used to verify any statistical significance between the observed and expected MCC rates in this patient group (p < 0.05).

Patient demographics and variables are examined in Tables 1 and 2, respectively. Of the 191 patients diagnosed with MCC, most patients (178 of the 191 or 93%) were White; of which 56 or 31% where White Hispanic. Seventy-one percent (136) were men and 81% (155) were over the age of 60 years old. The median time from symptom onset to diagnosis was 98 days. Significantly more tumours were located on the face/head/neck than on the trunk or limbs (p = 0.00). At diagnosis, most tumours were stage I or stage III (p = 0.00) and small (size ≤ 2 cm, p = 0.00). MCC was more common in men than in women, with differences in stage at diagnosis (p = 0.03) and regional lymph node status (p = 0.01) between the two sexes also being significant. Women were more likely to present at a lower stage and negative regional lymph node status, signifying nonmetastatic disease. Out of the 126 patients with known primary or secondary MCC, a significant majority (96 of 126 or 76.2%) had primary MCC. Most patients (132 of 187 or 70.6%) were also referred from another facility for treatment (p = 0.00) and had no other concurrent malignancy (110 of 165 or 66.7%, p = 0.00).

These results illustrate characteristics of MCC in a distinct, regionally Hispanic-predominant population. About one-third of the study population identified as Hispanic, and the majority of tumours were located on anatomical sites regularly exposed to sunlight. Although identification with an ethnic or racial group can be impacted by factors like skin colour, generational status and geographical nativity,2 our results suggest that actinic damage likely influences the development of MCC even in Hispanic populations. Moreover, most women in our cohort had nonmetastatic disease at presentation while most men had metastatic disease at presentation, suggesting possible delay in diagnosis, preferential referral to the University or more aggressive biology in men. It is known that MCC is a highly aggressive tumour, with metastasis being associated with lower survival rates and poorer outcomes.3 These findings align with recently published data showing women have improved survival.4 Interestingly, however, the range of time from symptom onset to diagnosis (20–638 days) was less than that of other tertiary care centres with similar published data.5

Although polyomavirus status in the study population was not found to be statistically significant, only about 25% (47 of 191) of our cohort underwent Merkel cell polyomavirus (MCPyV) testing. A total of 26 of these 47 patients (55.3%) were found to be virus-negative as compared to prior studies confirming MCPyV+ status in approximately 80% of cases.6, 7 Because MCPyV+ tumours have a better prognosis than MCPyV− tumours, identifying viral status is essential for prognostic predictability,7 especially in populations more likely to have sun-protected dark skin like Hispanic and Black patients. UV-driven versus virus-positive MCC prognostic data is still lacking for these populations even in large cohort studies,4, 8 and future studies are needed to see how viral status affects their MCC-specific survival.

Study conception and design, data interpretation, and draft manuscript preparation were performed by Kayla D. Mashoudy. Data analysis and interpretation and material preparation were performed by Anil Dalling. Data collection was done by Caitlin Dowell-Esquivel and Peyton V. Warp. Robert S. Kirsner commented on previous versions of the manuscript and reviewed the final manuscript. All authors reviewed the results and approved the final version of the manuscript.

The authors declare no conflict of interest.

This study was reviewed and approved by the University of Miami Institutional Review Board; approval #20230362. This material is the authors' own original work, which has not been previously published elsewhere.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信